Scholarlink

<p>Advances in hematopoietic stem cell transplantation (HSCT) and other cellular therapies have continued to improve the long-term outcomes for pediatric patients undergoing these treatments. However, treatment impacts on future fertility can have a substantial impact on the patient's quality of life. Concurrent with improvements in transplantation, fertility preservation (FP) options and outcomes have also evolved. Options such as ovarian tissue cryopreservation and testicular tissue cryopreservation are now more widely available and can be considered for very young patients. The timing and choice of FP to be offered can be complex, and many considerations must be made when counseling patients and families. Cost and access are also variable depending on the country and region in which a patient resides. The aim of this paper is to provide an updated overview of the current strategies and recommendations for FP that should be offered to all children and adolescents undergoing an allo-HSCT. By summarizing contemporary evidence and practices, this paper may provide support to clinicians in delivering equitable, informed, and accessible FP counseling and care for all eligible patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Andrea Jarisch,
  • Seth J. Rotz,
  • Alessandro Cattoni,
  • Blandine Courbiere,
  • Scott D. Lundy,
  • Kyle E. Orwig,
  • Catherine Poirot,
  • Jean-Hugues Dalle,
  • Rachel Phelan,
  • Tamara Diesch-Furlanetto

摘要

Advances in hematopoietic stem cell transplantation (HSCT) and other cellular therapies have continued to improve the long-term outcomes for pediatric patients undergoing these treatments. However, treatment impacts on future fertility can have a substantial impact on the patient's quality of life. Concurrent with improvements in transplantation, fertility preservation (FP) options and outcomes have also evolved. Options such as ovarian tissue cryopreservation and testicular tissue cryopreservation are now more widely available and can be considered for very young patients. The timing and choice of FP to be offered can be complex, and many considerations must be made when counseling patients and families. Cost and access are also variable depending on the country and region in which a patient resides. The aim of this paper is to provide an updated overview of the current strategies and recommendations for FP that should be offered to all children and adolescents undergoing an allo-HSCT. By summarizing contemporary evidence and practices, this paper may provide support to clinicians in delivering equitable, informed, and accessible FP counseling and care for all eligible patients.